Significant differences in outcome between Immunoscore categories in stage I colon cancer patients.

Authors

J Galon
F Hermitte
B Mlecnik
F Marliot
Carlo Bifulco, Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, ORFollow
A Lugli
I Nagtegaal
A Hartmann
M Van den Eynde
M Roehrl
P Ohashi
E Zavadova
T Torigoe
P Patel
Y Wang
Y Kawakami
F Marincola
P Ascierto
Bernard A Fox, Chiles Research Institute Providence Portland Medical CenterFollow
F Pagès

Document Type

Article

Publication Date

7-1-2019

Publication Title

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Keywords

genomics

Clinical Institute

Cancer

Department

Oncology

Department

Earle A. Chiles Research Institute

Recommended Citation

Galon, J; Hermitte, F; Mlecnik, B; Marliot, F; Bifulco, Carlo; Lugli, A; Nagtegaal, I; Hartmann, A; Van den Eynde, M; Roehrl, M; Ohashi, P; Zavadova, E; Torigoe, T; Patel, P; Wang, Y; Kawakami, Y; Marincola, F; Ascierto, P; Fox, Bernard A; and Pagès, F, "Significant differences in outcome between Immunoscore categories in stage I colon cancer patients." (2019). Articles, Abstracts, and Reports. 2822.
https://digitalcommons.providence.org/publications/2822